Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
04/2014
04/03/2014US20140093497 Anti-cd40 antibodies and uses thereof
04/03/2014US20140093494 Alpha synuclein toxicity
04/03/2014US20140093493 Method and formulation for reducing aggregation of a macromolecule under physiological conditions
04/03/2014US20140093492 Method for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
04/03/2014US20140093454 Human Monoclonal Antibodies Against CD20
04/03/2014US20140093449 Method for Preparing Largazole Analogs and Uses Thereof
04/02/2014EP2712930A2 Interferon alpha-induced pharmacodynamic markers
04/02/2014EP2712927A1 Recombinant vaccine against prrs in a viral vector
04/02/2014EP2712871A1 Recombinant Measles virus expressing Chikungunya virus polypeptides and their applications
04/02/2014EP2712626A1 Passive immunisation against influenza, in particular H5N1
04/02/2014EP2712625A1 Vaccines comprising TB 10.4
04/02/2014EP2712624A1 Combination vaccine comprising an attenuated bovine viral diharrhea virus
04/02/2014EP2712623A1 T-cell vaccine
04/02/2014EP2712320A1 Method for egfr directed combination treatment of cancer
04/02/2014EP2634194A9 Anti-cdh3 antibody having high internalization capacity
04/02/2014CN103703372A Anti-human receptor-type protein tyrosine phosphatase sigma antibody
04/02/2014CN103703133A Mutant replicon derived from genome of hepatitis c virus j6cf strain
04/02/2014CN103703129A Retention of antigen-binding molecules in blood plasma and method for modifying immunogenicity
04/02/2014CN103703027A Combination therapy with anti-CD19 antibody and purine analog
04/02/2014CN103703026A Monospecific and bispecific anti-igf-1r and anti-erbb3 antibodies
04/02/2014CN103702721A IL-21 epitope and IL-21 ligands
04/02/2014CN103702687A Synthetic nanocarriers that generate humoral and cytotoxic T lymphocyte (CTL) immune responses
04/02/2014CN103702685A Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
04/02/2014CN103702684A Combination vaccine
04/02/2014CN103702683A Combination therapy
04/02/2014CN103702682A Compositions and methods for the treatment of neuromyelitis optica
04/02/2014CN103695465A CDNA (Complementary Deoxyribonucleic Acid) infectious clone of porcine reproductive and respiratory syndrome virus vaccine strain and application thereof
04/02/2014CN103694353A Monoclonal antibodies against claudin-18 for treatment of cancer
04/02/2014CN103694352A CD26 antibody and preparation method thereof
04/02/2014CN103694351A Inhibitors of receptor tyrosine kinases and methods of use thereof
04/02/2014CN103694350A Cross-species-specific cd3-epsilon binding domain
04/02/2014CN103694349A Humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
04/02/2014CN103694348A Preparation and application method for treating swine viral diarrhea biological agent
04/02/2014CN103694347A Anti-human papilloma virus L1 protein antibody, and coding gene and application thereof
04/02/2014CN103694346A Anti-human papilloma virus L1 protein antibody, and coding gene and application thereof
04/02/2014CN103694345A Anti-human papilloma virus L1 protein antibody, and coding gene and application thereof
04/02/2014CN103694332A New tumor marker
04/02/2014CN103694326A Truncated-expressed protein antigen of chain A of abrin and application thereof
04/02/2014CN103694323A MntC recombinant protein of staphylococcus aureus and preparation method and application thereof
04/02/2014CN103694322A Staphylococcus aureus SpA5 mutant, as well as preparation method and application thereof
04/02/2014CN103694321A Staphylococcus aureus mSEB mutant and preparation method and application thereof
04/02/2014CN103694318A EV71 (Enterovirus 71) VP1 and RdRp (RNA dependent RNA polymerase) protein specific T cell epitope peptide as well as application thereof
04/02/2014CN103690951A Preparation method for veterinary medicine for resisting mink pseudomonas aeruginosa pneumonia
04/02/2014CN103690950A Application of P selectin inhibitor in prevention and treatment of rabbit portal vein thrombosis
04/02/2014CN103690949A Endomucin antibody medicament for prompting bone marrow regeneration
04/02/2014CN103690948A Oral colon-specific preparation for neutralizing anti-clostridium difficile toxin IgY (Immunoglobulin Y)
04/02/2014CN103690947A Antibodies to ox-2/cd200 and uses thereof
04/02/2014CN103690946A Alumina gel lipoid composite adjuvant
04/02/2014CN103690945A Reducing interference between oil-containing adjuvants and surfactant-containing antigens
04/02/2014CN103690944A Meningitis polysaccharide conjugate vaccine and preparing method thereof
04/02/2014CN103690943A Freeze-dried rabies vaccine for human use and preparation method thereof
04/02/2014CN103690942A Edwardsiella tarda subunit vaccine, and preparation and application thereof
04/02/2014CN103690941A Pseudomonas aeruginosa MSHA (Mannose-Sensitive Hemagglutinin) strain tumor vaccine and preparation method thereof
04/02/2014CN103690938A Application of beta subunit of adenosine triphosphate (ATP) synthesis enzyme in preparation of immune protective agent, vaccine or bacterial infection resistance agent
04/02/2014CN103184230B Fusion protein gene TAT-sVP7 and application thereof
04/02/2014CN103007272B Infectious chicken bronchitis vaccine
04/02/2014CN102994458B Porcine pseudorabies virus virulent strain, and gene deletion vaccine strain thereof and applications thereof
04/02/2014CN102964434B Recombinant encephalitis B virus and application thereof
04/02/2014CN102836430B Application of blocking antibody T5E3 to reversing of tumor multidrug resistance
04/02/2014CN102727887B Application of chitosan serving as immuno-adjuvant in preparing mouse allergic asthma model
04/02/2014CN102631672B Lyophilized inactivated Japanese encephalitis vaccine
04/02/2014CN102526719B Application of influenza vaccine in preparation of medicament for treating allergic diseases and allergy related diseases
04/02/2014CN102399785B Preparation method and purpose of immune nucleic acid (iRNA)
04/02/2014CN102292103B Purified plasmodium and vaccine compositions
04/02/2014CN102246045B Biomarkers and methods for detecting and treating spinal and joint pain
04/02/2014CN102174086B Porcine circovirus type 2 recombinant cap protein and subunit vaccine
04/02/2014CN102065890B Chimeric porcine circovirus PCV2Gen-1Rep and uses thereof
04/02/2014CN102050878B Anti-human CD20 humanized antibody and preparation method and application thereof
04/02/2014CN101897969B Use of complement inhibitors in preparing medicines for preventing or treating tissure damage
04/02/2014CN101875694B Antibody of TNF (Tumor Necrosis Factor) alpha and application thereof
04/02/2014CN101808660B Vaccine peptide combinations against cat allergy
04/02/2014CN101721698B Foot-and-mouth disease resistant vaccine composition and preparation and application thereof
04/02/2014CN101678092B Nucleic acids
04/02/2014CN101565457B Synthetic peptide vaccine and preparation method thereof
04/01/2014US8686119 Variants of humanized immunomodulatory monoclonal antibodies
04/01/2014US8685939 Vaccine targeting cellular death receptor DR5
04/01/2014US8685741 Methods for diagnosing irritable bowel syndrome
04/01/2014US8685734 Viral purification methods
04/01/2014US8685725 Monoclonal antibodies with enhanced ADCC function
04/01/2014US8685721 Stable constitutively high expression vector for preparing HPV vaccine and recombinant lactic acid bacteria transformed thereby
04/01/2014US8685694 Methods and compositions comprising bacteriophage nanoparticles
04/01/2014US8685670 Isolated chimeric proteins of modified lumazine synthase
04/01/2014US8685654 Assays for adsorbed influenza vaccines
04/01/2014US8685416 Compositions and methods for the treatment of cancer
04/01/2014US8685415 Mycobacterium mutants for vaccines with improved protective efficacy
04/01/2014US8685413 Heterologous protection against Pasteurella multocida provided by P. multocida fur cells and the outer-membrane protein extracts thereof
04/01/2014US8685412 Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing development of calicivirus disease
04/01/2014US8685411 Rotavirus antigens
04/01/2014US8685410 Influenza hemagglutinin and neuraminidase variants
04/01/2014US8685409 Influenza T-cell immunization against diverse influenza A viruses
04/01/2014US8685408 Compositions comprising a B subunit of Shiga toxin and a means stimulating NKT cells
04/01/2014US8685407 Genetic constructs and compositions comprising RRE and CTE and uses thereof
04/01/2014US8685406 Compositions of and method of using heat shock protein peptides
04/01/2014US8685405 Immunization of fish with plant-expressed recombinant proteins
04/01/2014US8685404 Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
04/01/2014US8685403 Insulin-like growth factor signaling and integrin
04/01/2014US8685402 Neutralizing anti-influenza A virus antibodies and uses thereof
04/01/2014US8685401 Methods of enhancing the response to radiation in tumor therapy using anti-DLL4 antibodies
04/01/2014US8685400 Modulating inflammasome activity and inflammation in the central nervous system
04/01/2014US8685399 PAX 5 monoclonal antibody
1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 1823